Pulse Biosciences (PLSE) Current Assets (2015 - 2025)

Pulse Biosciences has reported Current Assets for 11 years, with the latest figure at $83.4 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 30.16% year-over-year to $83.4 million; the trailing twelve-month figure through Dec 2025 stood at $83.4 million (down 30.16% YoY), and the FY2025 full-year result was $83.4 million, down 30.16% from the prior year.
• Current Assets for Q4 2025 stood at $83.4 million, down from $97.2 million in the prior quarter.
• The five-year high for Current Assets was $120.9 million in Q1 2025, with the low at $22.2 million in Q1 2022.
• Average Current Assets over 5 years is $64.1 million, with a median of $60.9 million recorded in 2021.
• Year-over-year, Current Assets sank 64.24% in 2022 and jumped 297.08% in 2025.
• Tracing PLSE's Current Assets over 5 years: stood at $45.3 million in 2021, then surged by 37.11% to $62.1 million in 2022, then decreased by 27.06% to $45.3 million in 2023, then jumped by 163.52% to $119.4 million in 2024, then tumbled by 30.16% to $83.4 million in 2025.
• The last three Current Assets figures came in at $83.4 million (Q4 2025), $97.2 million (Q3 2025), and $108.2 million (Q2 2025), per Business Quant data.

Peer Comparison